A new study has revealed the potential of a cannabinoid-based dietary supplement, Pain ReliefTM, to significantly alleviate chronic pain and improve the quality of life in dogs suffering from osteoarthritis.
Conducted by researchers from Columbia University, the University of Naples Federico II, and the University of Milano, the study was published in the peer-reviewed journal Animals.
For the study, 21 adult crossbreed dogs with severe osteoarthrosis participated. Researchers compared the effects of Pain Pain ReliefTM, a cannabis-based medicine produced by Giantec in Italy, to a placebo.
Continue reading